Showing results (681-690 of 1,351) with videos related to

Sort By:
Pageof 136
Clinical Pharmacology in Drug Development|January 12, 2017
Evaluation of Pharmacokinetic Interactions Between Lesinurad, a New Selective Urate Reabsorption Inhibitor, and Commonly Used Drugs for Gout TreatmentZancong Shen, Kathy Tieu, David Wilson, et al.
Clinical Pharmacology in Drug Development|March 7, 2017
Cure Strategies for Hepatitis B Virus: The Promise of ImmunotherapyNorah J Shire
Clinical Pharmacology in Drug Development|March 7, 2017
Mechanisms and Consequences of Drug-Drug InteractionsDavid J Greenblatt
Clinical Pharmacology in Drug Development|January 5, 2017
Absolute Bioavailability and Pharmacokinetic Comparability of Sirukumab Following Subcutaneous Administration by a Prefilled Syringe or an AutoinjectorY Zhuang, D E de Vries, S J Marciniak, et al.
Clinical Pharmacology in Drug Development|October 19, 2016
Pharmacokinetic and Bioequivalence Studies of a Newly Developed Branded Generic of Candesartan Cilexetil Tablets in Healthy VolunteersRajesh Patel, Jonathan L Palmer, Shashidhar Joshi, et al.
Clinical Pharmacology in Drug Development|August 27, 2022
Bioequivalence and Relative Bioavailability Studies to Assess a New Acalabrutinib Formulation That Enables Coadministration With Proton-Pump InhibitorsShringi Sharma, Xavier Pepin, Harini Burri, et al.
Clinical Pharmacology in Drug Development|September 1, 2022
Pharmacokinetics, Bioequivalence, and Safety of 2 Formulations of Hydroxychloroquine Tablets in Healthy Chinese Volunteers Under Fasting and Fed ConditionsHong-Yu Luo, Hui-Zhi Long, Zi-Wei Zhou, et al.
Clinical Pharmacology in Drug Development|October 20, 2022
Challenges in the Development of Intravenous Neurokinin-1 Receptor Antagonists: Results of a Safety and Pharmacokinetics Dose-Finding, Phase 1 Study of Intravenous FosnetupitantTimothy Tyler, Armin Schultz, Alessio Venturini, et al.
Clinical Pharmacology in Drug Development|May 4, 2016
Effect of food on the pharmacokinetics of canagliflozin, a sodium glucose co-transporter 2 inhibitor, and assessment of dose proportionality in healthy participantsDamayanthi Devineni, Prasarn Manitpisitkul, Joseph Murphy, et al.
Clinical Pharmacology in Drug Development|May 4, 2016
Absolute oral bioavailability and pharmacokinetics of canagliflozin: A microdose study in healthy participantsDamayanthi Devineni, Joseph Murphy, Shean-Sheng Wang, et al.
Pageof 136